Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.910
0.00 (0.00%)
At close: Jul 28, 2026, 4:00 PM EDT
2.860
-0.050 (-1.72%)
After-hours: Jul 28, 2026, 7:54 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $184.36 million as of July 28, 2026. Its market cap has increased by 138.09% in one year.
Market Cap
184.36M
Enterprise Value
161.60M
1-Year Change
138.09%
Ranking
Category
Stock Price
$2.91
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $184.36M, a decrease of -64.80%. That is a compound annual growth rate of -19.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 184.36M | 157.48% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 171.07M |
| Corbus Pharmaceuticals Holdings | 169.90M |
| Innate Pharma | 169.81M |
| Humacyte | 168.47M |
| Tenaya Therapeutics | 168.17M |
| Karyopharm Therapeutics | 167.93M |
| OnKure Therapeutics | 166.43M |
| Oramed Pharmaceuticals | 164.93M |